Business Model: B2B Non-Profit
Revenue: $0
Employees: 0-0
Address:
City:
State:
Zip:
Country:
Capital Community Angel Investors (CCAI) is a nonprofit organization that seeks to introduce qualified entrepreneurs to its member investors. The group looks for Michigan-based “disruptive” early stage investments that offer sustainable competitive advantage. We do not consider investments in companies located primarily outside of Michigan, or companies in service industries such as real estate, retail businesses, restaurants, or other “lifestyle” enterprises. The members of CCAI are individual investors seeking to fund innovative early stage ventures and startups. Potential members should either have prior early stage investment experience or have a strong desire and capability to learn about and engage in such investments. Our members share the responsibilities associated with evaluating the merits of potential investments, but each member individually decides whether to participate in each investment opportunity. Given the obvious risk of early stage ventures and startups, members must qualify as an accredited investor, as defined under Rule 501 of SEC Regulation D.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
12/2020 | ONL Therapeutics | Series B | 0 |
7/2014 | ONL Therapeutics | Seed Round | 501.8k |
9/2015 | HistoSonics | Debt Financing | 3.5M |
7/2007 | XG Sciences | Venture Round | - |
10/2013 | Biophotonic Solutions | Series A | 1M |
5/2017 | ONL Therapeutics | Series A | 0 |
3/2011 | Accio Energy | Convertible Note | - |
1/2013 | Are You a Human | Venture Round | 900k |
8/2014 | Vestaron | Series C | 0 |
8/2019 | ONL Therapeutics | Convertible Note | 0 |
2/2014 | VNN | Series A | 0 |
5/2012 | Vestaron | Series B | 10.2M |
11/2014 | Avegant | Series A | 9.4M |
9/2015 | VNN | Venture Round | 0 |
9/2008 | XG Sciences | Convertible Note | - |
11/2013 | Avegant | Venture Round | 1.9M |
12/2020 | ONL Therapeutics | Series B | 0 |
8/2019 | ONL Therapeutics | Convertible Note | 0 |
5/2017 | ONL Therapeutics | Series A | 0 |
9/2015 | HistoSonics | Debt Financing | 0 |
9/2015 | VNN | Venture Round | 0 |
11/2014 | Avegant | Series A | 0 |
8/2014 | Vestaron | Series C | 0 |
7/2014 | ONL Therapeutics | Seed Round | 0 |
2/2014 | VNN | Series A | 0 |
11/2013 | Avegant | Venture Round | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|